FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to single-dose pharmaceutical compositions of (R)-pramipexole of high chiral purity, and to methods of using said compositions for treating neurodegenerative diseases or diseases associated with mitochondrial dysfunction or high oxidative stress.
EFFECT: group of inventions enables inhibiting or delaying the developing pathologies and/or symptoms by administering a single dose of the (R)-pramipexole composition.
29 cl, 5 dwg, 18 tbl, 17 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SYNTHESIS OF CHIRALLY PURE SUBSTITUTED BENZOTHIAZOLE DIAMINES | 2008 |
|
RU2454409C2 |
| ANALGETIC COMPOSITION AND A METHOD OF ANALGETIC EFFECT ATTAINMENT IN HUMAN | 1993 |
|
RU2125873C1 |
| METHOD OF REDUCING AMYLOID DEPOSITION, AMYLOID NEUROTOXICITY AND MICROGLYOSIS BY (-)-ENANTIOMER NILVADIPINE | 2008 |
|
RU2490014C2 |
| NEW PHARMACEUTICAL COMPOSITIONS FOR SEXUAL DISORDERS | 2005 |
|
RU2445095C2 |
| THERAPEUTIC COMPOUNDS | 2008 |
|
RU2470907C2 |
| COMPOSITIONS AND METHODS ASSOCIATED THEREWITH | 2017 |
|
RU2764716C2 |
| AMINOPYRAZOLES AS SELECTIVE JANUS KINASE INHIBITORS | 2017 |
|
RU2757218C2 |
| THERAPEUTIC COMPOUNDS | 2008 |
|
RU2470908C2 |
| DELAYED RELEASE PILL CONTAINING REBOXETIN | 2003 |
|
RU2292873C2 |
| TREATING MALIGNANT TUMORS USING PIZ-KINASE ISOFORM MODULATORS | 2014 |
|
RU2705204C2 |
